title: Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
abstract: BACKGROUND
  Endoscopic sclerotherapy is an accepted treatment for bleeding esophageal varices, but it is associated with substantial local and systemic complications. Endoscopic ligation, a new form of endoscopic treatment for bleeding varices, may be safer. We compared the effectiveness and safety of the two techniques.
  
  
  METHODS
  In this randomized trial we compared endoscopic sclerotherapy and endoscopic ligation in 129 patients with cirrhosis who had proved bleeding from esophageal varices. Sixty-five patients were treated with sclerotherapy, and 64 with ligation. Initial treatment for acute bleeding was followed by elective retreatment to eradicate varices. The patients were followed for a mean of 10 months, during which we determined the incidence of complications and recurrences of bleeding, the number of treatments needed to eradicate varices, and survival.
  
  
  RESULTS
  Active bleeding at the first treatment was controlled by sclerotherapy in 10 of 13 patients (77 percent) and by ligation in 12 of 14 patients (86 percent). Slightly more sclerotherapy-treated patients had recurrent hemorrhage during the study (48 percent vs. 36 percent for the ligation-treated patients, P = 0.072). The eradication of varices required a lower mean (+/- SD) number of treatments with ligation (4 +/- 2 vs. 5 +/- 2, P = 0.056) than with sclerotherapy. The mortality rate was significantly higher in the sclerotherapy group (45 percent vs. 28 percent, P = 0.041), as was the rate of complications (22 percent vs. 2 percent, P less than 0.001). The complications of sclerotherapy were predominantly esophageal strictures, pneumonias, and other infections.
  
  
  CONCLUSIONS
  Patients with cirrhosis who have bleeding esophageal varices have fewer treatment-related complications and better survival rates when they are treated by esophageal ligation than when they are treated by sclerotherapy.
authors.affiliation: Department of Surgery, University of Colorado, Denver.
authors.forename: G V
authors.initials: GV
authors.lastname: Stiegmann
authors.forename: J S
authors.initials: JS
authors.lastname: Goff
authors.forename: P A
authors.initials: PA
authors.lastname: Michaletz-Onody
authors.forename: J
authors.initials: J
authors.lastname: Korula
authors.forename: D
authors.initials: D
authors.lastname: Lieberman
authors.forename: Z A
authors.initials: ZA
authors.lastname: Saeed
authors.forename: R M
authors.initials: RM
authors.lastname: Reveille
authors.forename: J H
authors.initials: JH
authors.lastname: Sun
authors.forename: S R
authors.initials: SR
authors.lastname: Lowenstein
mesh_terms: D004932:Esophageal and Gastric Varices / Q000628:therapy*; D004945:Esophagoscopy; D004947:Esophagus / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000628:therapy*; D006801:Humans; D007258:Informed Consent; D008026:Ligation / Q000379:methods; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012008:Recurrence; D015911:Sclerotherapy / Q000009:adverse effects / Q000379:methods; D015996:Survival Rate